HRT Financial’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

HRT Financial’s Portfolio PBLA Stock Details PBLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,907	Closed	-$34K	–	3377
2023 Q4	$34K	Buy	+1,907	New	+$29.8K	﹤0.01%	1992
2023 Q2	–	Sell	-114	Closed	-$30K	–	3668
2023 Q1	$30K	Buy	+114	New	+$110K	﹤0.01%	2158

HRT Financial's PBLA Position: Q1 2024 in Review

HRT Financial sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q1 2024, closing a stake of 1,907 shares — an estimated $34K sold.

HRT Financial first reported a position in PBLA in Q1 2023 and held it in 2 quarters. The position peaked at $34K in Q4 2023. 0 funds tracked by Wall St. Rank hold PBLA as of Q1 2024.

HRT Financial reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 1,907 Panbela Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $34K.
HRT Financial first reported a position in Panbela Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
HRT Financial's Panbela Therapeutics, Inc. Common Stock position peaked at $34K in Q4 2023.
0 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.